Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
In this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss the testing, affects, and potential marketing of a new insulin delivery system currently undergoing trials. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. …
Read More »Daily Archives: Sep 17, 2016
Dr. Robert Geho, Part 7 – Going to Market
In Part 7, the final installment of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the potential marketing and timing of the product offering. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the …
Read More »Dr. Robert Geho, Part 6 – Reduction in Insulin Use
In Part 6 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho and Diabetes in Control publisher Steve Freed discuss the possible reduction in the use of insulin as well as hypoglycemia following the use of the product. Robert Geho, MD, is a co-founder and CEO …
Read More »Dr. Robert Geho, Part 5 – Weight Impact
In Part 5 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the potential effect of the proper storage of insulin within the liver on the overall weight of the patient. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In …
Read More »Dr. Robert Geho, Part 4 – The Benefits of Mixed Insulin
In Part 4 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, understanding the best insulin for the admixture and the possible effect on A1C. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the management and strategic …
Read More »Dr. Robert Geho, Part 3 – Early Trials?
In Part 3 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the focus on the phase of trials. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the management and strategic direction of …
Read More »Dr. Robert Geho, Part 2 – Effect of Insulin on Liver
In Part 2 of this Exclusive Interview from the 2016 Diabetes Symposium in Boston, Dr. Robert Geho explains the effect of insulin on the liver. Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the management and strategic direction of …
Read More »Dr. Robert Geho, Part 1 – Diasome Drug Delivery System
In Part 1 of this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss a new drug delivery system designed to deliver insulin molecules that are currently sold as commercial insulins to cells in the liver. Robert Geho, …
Read More »